| Net Cash Provided by (Used in) Operating Activities |
$28,558,650 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$13,660,357 |
USD |
-214% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
45,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
14,962,410 |
shares |
22% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$14,898,293 |
USD |
|
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$7,229,674 |
USD |
497% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$52,239,634 |
USD |
52% |
Q4 2024 |
FY 2024 |
| Depreciation |
$33,622 |
USD |
25% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$13,279,522 |
USD |
-0.69% |
Q2 2024 |
Q2 2024 |
| Deferred Income Tax Expense (Benefit) |
$223,681 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$15,009,092 |
USD |
119% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
15,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$2,700,000 |
USD |
14% |
Q3 2025 |
Q3 2025 |